Diabetes technology (DT) has accomplished tremendous progress in the past decades,
aiming to convert these technologies as viable treatment options for the benefit of patients …

Management of patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus
(T2DM) on intensive insulin therapy consists of 2 integral parts: glucose measurement and …

Randomized controlled trials, which are considered the highest level of scientific evidence,
have shown significant glycemic benefits associated with use of continuous glucose …

Numerous randomized controlled trials (RCTs) have demonstrated the glycemic benefits of
continuous glucose monitoring (CGM) in management of type 1 diabetes (T1D) and type 2 …

Applications and systems for diabetes self‐management are growing and involve a vast
majority of factors to consider. This study was aimed at examining the integration of portable …

Background: Infusion set function remains the limiting factor of insulin pump therapy due to
nonmetabolic complications. Here, we tested an investigational extended-wear infusion set …

The approximation of euglycemia is the most effective means of preventing diabetic
complications, which is achieved through effective insulin delivery. Recent reports indicate …

Fast-acting insulin aspart (faster aspart) is an ultra-rapid-acting formulation of insulin aspart
developed to more closely match the prandial endogenous insulin profile, and its …

Aim To evaluate the long-term clinical effect of continuous subcutaneous insulin infusion
(CSII) in adult type 1 diabetes mellitus (T1DM) patients in a regional public healthcare …

Aims The aim of this study was to compare individuals with type 1 diabetes with continuous
subcutaneous insulin infusion (CSII) and intensified insulin therapy (ICT) in routine care …